Recommended Topic Related To:

Kaletra Capsules

"Increasing HIV prevention and treatment options make it more important than ever to get tested and know your status.

September 27 is National Gay Men's HIV/AIDS Awareness Day, a time to reflect on the heavy toll of HIV among gay and bis"...

Kaletra Capsules

Kaletra Capsules

INDICATIONS

KALETRA is indicated in combination with other antiretroviral agents for the treatment of HIV1 infection in adults and pediatric patients (14 days and older).

The following points should be considered when initiating therapy with KALETRA:

  • The use of other active agents with KALETRA is associated with a greater likelihood of treatment response [see Microbiology and Clinical Studies].
  • Genotypic or phenotypic testing and/or treatment history should guide the use of KALETRA [see Microbiology]. The number of baseline lopinavir resistance-associated substitutions affects the virologic response to KALETRA [see Microbiology].

DOSAGE AND ADMINISTRATION

KALETRA Capsules must be taken with food.

Adult Patients

  • KALETRA Capsules 400/100 mg (given as three 133/33 mg capsules) twice daily.
  • KALETRA Capsules 800/200 mg (given as six 133/33 mg capsules) once daily in patients with less than three lopinavir resistance-associated substitutions.

Once daily administration of KALETRA is not recommended for adult patients with three or more of the following lopinavir resistance-associated substitutions: L10F/I/R/V, K20M/N/R, L24I, L33F, M36I, I47V, G48V, I54L/T/V, V82A/C/F/S/T, and I84V [see Microbiology].

KALETRA should not be administered once daily in combination with carbamazepine, phenobarbital, or phenytoin [see DRUG INTERACTIONS].

Concomitant therapy: Efavirenz, Nevirapine, or Nelfinavir

[see CLINICAL PHARMACOLOGY and DRUG INTERACTIONS]

KALETRA capsules should not be administered as a once-daily regimen in combination with efavirenz, nevirapine, or nelfinavir.

  • A dose increase is recommended for all patients who use KALETRA capsules. The recommended dose of KALETRA Capsules is 533/133 mg twice daily (given as four 133/33 mg capsules twice daily taken with food) when used in combination with efavirenz, nevirapine, or nelfinavir.

Pediatric Patients

KALETRA Capsules should not be administered once daily in pediatric patients less than 18 years of age.

For children less than 12 years of age who weigh greater than 40 kg or for children greater than 12 years of age, the maximum dose of 400/100 mg twice daily (given as three 133/33 mg capsules twice daily taken with food) is recommended.

The use of KALETRA oral solution is recommended for children 14 days to 12 years of age who weigh less than 40 kg and in those children who cannot swallow capsules. Please refer to the KALETRA oral solution full prescribing information for pediatric dosage and administration and other important information for these children.

Concomitant Therapy: Efavirenz, Nevirapine, or Nelfinavir

A dose increase is recommended for all pediatric patients who use KALETRA capsules. For children weighing more than 45 kg, the recommended dose of KALETRA capsules is 533/133 mg twice daily (given as four 133/33 mg capsules twice daily taken with food) when used in combination with efavirenz, nevirapine, or nelfinavir.

HOW SUPPLIED

Dosage Forms And Strengths

KALETRA (lopinavir/ritonavir) Capsules are orange soft gelatin capsules imprinted with the corporate Abbott “A” logo and the Abbo-Code PK. KALETRA is available as 133.3 mg lopinavir/33.3 mg ritonavir capsules.

Storage And Handling

KALETRA (lopinavir/ritonavir) Capsules are orange soft gelatin capsules imprinted with the corporate Abbott “A” logo and the Abbo-Code PK. KALETRA is available as 133.3 mg lopinavir/33.3 mg ritonavir capsules in the following package sizes:

Bottles of 180 capsules each….…………… (NDC 0074-3959-77)

Recommended storage: Store KALETRA Soft Gelatin Capsules at 36 - 46°F (2 - 8°C) until dispensed. Avoid exposure to excessive heat. For patient use, refrigerated KALETRA Capsules remain stable until the expiration date printed on the label. If stored at room temperature up to 77°F (25°C), capsules should be used within 2 months.

Rev. 01/2013. Abbott Laboratories North Chicago, IL 60064 USA

Last reviewed on RxList: 2/6/2013
This monograph has been modified to include the generic and brand name in many instances.

A A A

Kaletra Capsules - User Reviews

Kaletra Capsules User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Kaletra Capsules sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


WebMD Daily

Get breaking medical news.

advertisement
advertisement
Use Pill Finder Find it Now See Interactions

Pill Identifier on RxList

  • quick, easy,
    pill identification

Find a Local Pharmacy

  • including 24 hour, pharmacies

Interaction Checker

  • Check potential drug interactions
Search the Medical Dictionary for Health Definitions & Medical Abbreviations